PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 153 filers reported holding PORTOLA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $74,000 | -77.8% | 10,435 | -25.4% | 0.04% | -72.8% |
Q4 2019 | $334,000 | -15.0% | 13,985 | -4.5% | 0.14% | -17.6% |
Q3 2019 | $393,000 | -2.7% | 14,650 | -1.6% | 0.16% | -9.3% |
Q2 2019 | $404,000 | -21.4% | 14,883 | +0.6% | 0.18% | -26.3% |
Q1 2019 | $514,000 | +96.2% | 14,800 | +10.4% | 0.25% | +66.9% |
Q4 2018 | $262,000 | -30.1% | 13,400 | -5.0% | 0.15% | -20.9% |
Q3 2018 | $375,000 | -28.8% | 14,100 | +1.0% | 0.19% | -33.5% |
Q2 2018 | $527,000 | +21.7% | 13,960 | +5.3% | 0.28% | +20.6% |
Q1 2018 | $433,000 | -28.9% | 13,260 | +6.0% | 0.23% | -26.3% |
Q4 2017 | $609,000 | -14.0% | 12,510 | -4.6% | 0.32% | -19.2% |
Q3 2017 | $708,000 | +5.0% | 13,110 | +9.2% | 0.39% | -3.0% |
Q2 2017 | $674,000 | +51.5% | 12,000 | +5.7% | 0.40% | +36.6% |
Q1 2017 | $445,000 | +74.5% | 11,350 | 0.0% | 0.30% | +60.3% |
Q4 2016 | $255,000 | -3.0% | 11,350 | -2.2% | 0.18% | -14.0% |
Q3 2016 | $263,000 | -4.0% | 11,600 | 0.0% | 0.21% | -10.8% |
Q2 2016 | $274,000 | – | 11,600 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 1,220,672 | $55,602,000 | 9.30% |
Fernwood Investment Management, LLC | 201,211 | $9,165,000 | 7.20% |
Cormorant Asset Management, LP | 500,000 | $22,775,000 | 3.03% |
Ghost Tree Capital, LLC | 170,000 | $7,744,000 | 2.51% |
HARVEY CAPITAL MANAGEMENT INC | 155,030 | $7,108,000 | 2.40% |
SECTORAL ASSET MANAGEMENT INC | 1,169,130 | $53,254,000 | 2.22% |
Atika Capital Management LLC | 98,000 | $4,464,000 | 2.01% |
Temasek Holdings (Private) Ltd | 5,833,568 | $265,719,000 | 1.66% |
CABOT WEALTH MANAGEMENT INC | 124,309 | $5,662,000 | 1.38% |
EMERALD MUTUAL FUND ADVISERS TRUST | 314,689 | $14,334,000 | 1.11% |